VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 174 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $398,244 | -54.1% | 92,186 | -30.0% | 0.00% | – |
| Q2 2023 | $867,936 | -4.5% | 131,705 | -1.6% | 0.00% | – |
| Q1 2023 | $909,256 | -11.4% | 133,911 | -3.6% | 0.00% | – |
| Q4 2022 | $1,026,456 | +121.2% | 138,898 | +195.5% | 0.00% | – |
| Q3 2022 | $464,000 | -26.3% | 47,003 | -18.6% | 0.00% | – |
| Q2 2022 | $630,000 | -57.9% | 57,743 | -56.4% | 0.00% | – |
| Q1 2022 | $1,498,000 | +74.0% | 132,486 | +141.3% | 0.00% | – |
| Q4 2021 | $861,000 | +1.3% | 54,908 | +10.6% | 0.00% | – |
| Q3 2021 | $850,000 | +1365.5% | 49,624 | +1737.2% | 0.00% | – |
| Q2 2021 | $58,000 | -94.8% | 2,701 | -96.3% | 0.00% | – |
| Q1 2021 | $1,108,000 | +30.8% | 73,764 | +14.4% | 0.00% | – |
| Q4 2020 | $847,000 | +764.3% | 64,490 | +537.8% | 0.00% | – |
| Q3 2020 | $98,000 | -66.9% | 10,111 | -60.9% | 0.00% | – |
| Q2 2020 | $296,000 | +1038.5% | 25,859 | +912.1% | 0.00% | – |
| Q1 2020 | $26,000 | -97.9% | 2,555 | -96.6% | 0.00% | – |
| Q4 2019 | $1,234,000 | +17.1% | 75,179 | -5.3% | 0.00% | – |
| Q3 2019 | $1,054,000 | +1071.1% | 79,388 | +1151.8% | 0.00% | – |
| Q2 2019 | $90,000 | -29.1% | 6,342 | -8.6% | 0.00% | – |
| Q1 2019 | $127,000 | -97.1% | 6,942 | -95.9% | 0.00% | -100.0% |
| Q4 2018 | $4,454,000 | +660.1% | 170,446 | +567.4% | 0.00% | – |
| Q3 2018 | $586,000 | +205.2% | 25,539 | +153.4% | 0.00% | – |
| Q2 2018 | $192,000 | -86.6% | 10,079 | -88.1% | 0.00% | -100.0% |
| Q1 2018 | $1,428,000 | +50.8% | 84,739 | +35.9% | 0.00% | – |
| Q4 2017 | $947,000 | -65.7% | 62,357 | -59.5% | 0.00% | -100.0% |
| Q3 2017 | $2,759,000 | +1074.0% | 154,105 | +967.4% | 0.00% | – |
| Q2 2017 | $235,000 | +42.4% | 14,438 | +22.1% | 0.00% | – |
| Q1 2017 | $165,000 | -75.2% | 11,820 | -71.7% | 0.00% | – |
| Q4 2016 | $666,000 | +108.8% | 41,698 | +118.2% | 0.00% | – |
| Q3 2016 | $319,000 | -19.4% | 19,112 | -45.9% | 0.00% | – |
| Q2 2016 | $396,000 | +91.3% | 35,349 | +42.6% | 0.00% | – |
| Q1 2016 | $207,000 | -83.9% | 24,786 | -82.1% | 0.00% | -100.0% |
| Q4 2015 | $1,288,000 | +293.9% | 138,346 | +377.1% | 0.00% | – |
| Q3 2015 | $327,000 | -10.7% | 29,000 | +0.8% | 0.00% | – |
| Q2 2015 | $366,000 | -73.6% | 28,778 | -80.7% | 0.00% | -100.0% |
| Q1 2015 | $1,388,000 | +4106.1% | 149,300 | +6391.3% | 0.00% | – |
| Q4 2014 | $33,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |